Constitutive Signaling by Aberrant PI3K in Cancer

Human

3,860 primer pairs across 86 of 86 genes in this pathway.

GenePrimer pairs
AREG10View all 10
BDNF170View all 170
BTC20View all 20
CD1930View all 30
CD2830View all 30
CD8010View all 10
CD8650View all 50
EGF40View all 40
EGFR90View all 90
EPGN50View all 50
ERBB2300View all 300
ERBB320View all 20
ERBB420View all 20
EREG10View all 10
ESR1120View all 120
ESR270View all 70
FGF1270View all 270
FGF1010View all 10
FGF1610View all 10
FGF1720View all 20
FGF1810View all 10
FGF1910View all 10
FGF220View all 20
FGF2010View all 10
FGF2220View all 20
FGF2310View all 10
FGF310View all 10
FGF410View all 10
FGF530View all 30
FGF610View all 10
FGF710View all 10
FGF850View all 50
FGF910View all 10
FGFR1130View all 130
FGFR2120View all 120
FGFR350View all 50
FGFR450View all 50
FLT310View all 10
FLT3LG50View all 50
FRS280View all 80
FYN40View all 40
GAB120View all 20
GAB220View all 20
GRB220View all 20
HBEGF10View all 10
HGF50View all 50
ICOS10View all 10
IRS110View all 10
IRS210View all 10
KIT80View all 80
KITLG20View all 20
KL10View all 10
KLB10View all 10
LCK30View all 30
MET40View all 40
NRG1230View all 230
NRG250View all 50
NRG370View all 70
NRG410View all 10
NTF320View all 20
NTF410View all 10
NTRK2270View all 270
NTRK3110View all 110
PDGFA20View all 20
PDGFB20View all 20
PDGFRA50View all 50
PDGFRB30View all 30
PIK3AP110View all 10
PIK3CA10View all 10
PIK3CB20View all 20
PIK3CD30View all 30
PIK3CG30View all 30
PIK3R140View all 40
PIK3R210View all 10
PIK3R3110View all 110
PIK3R560View all 60
PIK3R620View all 20
PTPN1140View all 40
RAC120View all 20
RAC210View all 10
RHOG10View all 10
SRC20View all 20
STRN10View all 10
TGFA40View all 40
TRAT120View all 20
VAV130View all 30

Source: R-HSA-2219530 · Pathway data from Reactome, released under CC0.

A free tool by Cytogence®

Product Search Primers About Methodology Cite Us
Legal Privacy Policy Terms of Service

© 2026 KeyQ, Inc. All rights reserved. KeyQ® and Cytogence® are registered trademarks of KeyQ, Inc. PrimerGenie is a service of Cytogence, a division of KeyQ, Inc.

Primers are computationally predicted and not experimentally validated unless indicated by community reviews. For research use only.